Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Polyganics takes transparent nerve guide to the EU:

This article was originally published in Clinica

Executive Summary

Dutch firm Polyganics has gained EU market clearance for its resorbable and transparent synthetic nerve guide, Neurolac, for repairing peripheral nerve damage. The tube-shaped device is sutured to both ends of the transected nerve and guides the outgrowing nerve in a protective environment, preventing neuroma formation. After the nerve function has been restored, the nerve guide is resorbed by the body. The product's transparency, which the Groningen firm says is a first-of-its-kind in Europe, allows surgeons to see what they are doing and facilitates easy and reliable closure of the nerve gap. Neurolac is already cleared in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058374

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel